申请人:Ono Pharmaceutical Co., Ltd.
公开号:US04355170A1
公开(公告)日:1982-10-19
The imidazole derivatives of the general formula: ##STR1## wherein R.sup.1 represents a hydrogen atom, or a straight- or branched-chain alkyl group containing from 1 to 12 carbon atoms, R.sup.2 represents a hydrogen atom, or a straight- or branched-chain alkyl group containing from 1 to 4 carbon atoms, R.sup.3 represents a straight- or branched-chain alkyl group containing from 1 to 10 carbon atoms, and m and n, which may be the same or different, each represent zero, or an integer of 1 to 10, and non-toxic acid addition salts thereof, and, when R.sup.1 represents a hydrogen atom, non-toxic salts thereof, are new compounds. These compounds have a strong inhibitory effect on thromboxane synthetase from rabbit platelet microsomes, and are useful as therapeutically active agents for inflammation, hypertension, thrombus, cerebral apoplexy and asthma.
通式为 ##STR1## 的咪唑衍生物,其中 R.sup.1 代表氢原子,或者含有1到12个碳原子的直链或支链烷基,R.sup.2 代表氢原子,或者含有1到4个碳原子的直链或支链烷基,R.sup.3 代表含有1到10个碳原子的直链或支链烷基,m和n可以相同也可以不同,分别代表0或1到10的整数,以及其无毒酸加成盐,当R.sup.1代表氢原子时,还包括其无毒盐。这些化合物对于兔血小板微粒体中的血栓素合成酶具有强烈的抑制作用,并且可用作治疗活性剂,用于炎症,高血压,血栓,脑卒中和哮喘。